FDA
approval
· 2025-01-22
FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
Summary
The FDA approved ANI Pharmaceuticals' supplemental application for fluphenazine hydrochloride, a generic antipsychotic used to treat schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)